Literature DB >> 9661211

Naso-temporal asymmetry of spatial interactions in strabismic amblyopia.

C Yu1, D M Levi.   

Abstract

PURPOSE: Naso-temporal asymmetries of visual acuity and contrast sensitivity have been reported in strabismic amblyopia and attributed to asymmetries of interocular suppression. In this study, we investigated the naso-temporal asymmetry of cortical spatial interactions in two strabismic amblyopes (one esotrope and one exotrope).
METHODS: Length and width Westheimer functions were measured on both amblyopes at the 10 deg retinal eccentricity of both nasal and temporal visual fields.
RESULTS: Spatial interactions in the two amblyopic eyes were more degraded in the temporal visual fields than in the nasal visual fields. A comparison with results from the preferred eyes suggested that this asymmetry was caused mainly by a loss of spatial interactions in the temporal visual fields of amblyopic eyes, with those in the nasal visual fields being normal.
CONCLUSION: Our results suggest that intracortical connections underlying cortical spatial interactions might have been degraded by amblyopia. This degradation exists not only in the areas of the strabismic visual cortex responding to foveal stimuli but also in those responding to stimuli presented in the temporal visual fields.

Entities:  

Mesh:

Year:  1998        PMID: 9661211     DOI: 10.1097/00006324-199806000-00026

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  2 in total

1.  Topographical profiles of macula and optic nerve head in concomitant strabismus patients as measured using OCT and CSLO.

Authors:  Yun Wen; Jianhua Yan; Zhonghao Wang; Tao Shen; Xuan Qiu; Daming Deng; Jingchang Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-21       Impact factor: 3.117

2.  Disruption of Positional Encoding at Small Separations in the Amblyopic Periphery.

Authors:  Zahra Hussain; Paul V McGraw
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-04-01       Impact factor: 4.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.